Former Massachusetts Cannabis Regulator and State Sen. Jennifer Flanagan Joins National Cannabis Law Firm Vicente Sederberg LLP as Director of Regulatory Policy

Flanagan announced April 13 she planned to step down from her seat as the state’s cannabis control commissioner.


BOSTON, May 3, 2021 – PRESS RELEASE – Former Massachusetts Cannabis Control Commissioner Jennifer Flanagan joined national cannabis law firm Vicente Sederberg LLP on Monday as director of regulatory policy, a newly developed role at the firm.  

Cannabis Control Commission
Jennifer Flanagan joined national cannabis law firm Vincente Sederberg Monday. 

Flanagan was elected to the Massachusetts House of Representatives in 2005, then to the state Senate in 2009, where she served two terms. In 2017, Gov. Charlie Baker appointed her to serve as the first public health representative on the newly formed Cannabis Control Commission. During her time as a commissioner, she led efforts to protect public health and patients’ rights, including the award-winning “More About Marijuana” public education campaign.

RELATED: Cannabis Control Commissioner Jennifer Flanagan Announces Departure from the Agency on April 30

“Jennifer devoted 25 years to public service in Massachusetts, and we are honored to welcome her to Vicente Sederberg,” said Adam Fine, managing partner of the firm’s Boston office. “Her experience as both an elected official and regulator, combined with her career-spanning advocacy work, offers her a unique perspective on cannabis policy. She will be an invaluable asset to our clients and to government officials across the country as they work to develop and implement responsible cannabis and hemp regulations.”

Now in its 11th year of operation, Vicente Sederberg continues to grow in its service offerings and geographical reach as cannabis policy reform spreads across the U.S. and around the globe. 

“Throughout my four years with the commission, I watched the Vicente Sederberg team passionately and effectively advocate not only for their clients, but also for thoughtful public policy and the collective welfare of the regulated cannabis industry,” Flanagan said. “I’m grateful for this opportunity to take on a new role that ties together my cannabis regulatory experience with my commitment to public health advocacy. I look forward to working with VS and other cannabis industry leaders on matters that advance the industry in a responsible, inclusive, and compliant manner.”